Decompression Sickness Clinical Trial
Official title:
Phase 1 Study Investigating Alterations of Circulating Microparticles in Scuba Divers With Decompression Sickness
The investigators hypothesize that membrane microparticles (MPs) are liberated into the blood stream in response to decompression stress and that certain MPs characteristics initiate inflammatory responses that contribute to the clinical syndrome the investigators call decompression sickness. The research goal is to evaluate the number, type and time-course for elevations in MPs in sport SCUBA divers who present for treatment of decompression sickness. Blood samples are to be taken from consenting patients before and after they undergo treatment for decompression sickness and at a follow-up clinic visit from 1 to 3 weeks later (three samples total).
Microparticles (MPs) are small membrane bound vesicles shed from the surface of a variety of cells by what appear to be well regulated processes. They are elevated in many physiological and disease states and in some instances have been associated with organ injury. Shear stress - as can be caused by intravascular bubbles - is one of the stimuli known to cause cells to release microparticles. Most sport SCUBA dives have been shown to generate intravascular bubbles - even safe dives well within limits established by the US Navy and sports authorities. The investigators have reported elevations in several sub-types of MPs in a group of individuals undergoing a well monitored series of open-water SCUBA dives. There is no information of the occurrence of MPs in injured divers. The investigators have published results using a murine model which demonstrated that mice subjected to varying decompression stresses exhibit progressive elevations in circulating MPs derived from leukocytes, erythrocytes, platelets and endothelial cells. Using novel interventions the investigators demonstrated that MPs cause intravascular neutrophil activation and inflammatory perivascular injuries. Therefore, there is pathophysiological information to suggest that one or more element of MPs (number and/or pro-inflammatory subtype) may be proximal elements that precipitate the clinical syndrome the investigators call decompression sickness. ;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02118207 -
Exercise and Repetitive Diving
|
N/A | |
Completed |
NCT02468752 -
Reduction of Venous Emboli Load After Breathing Normobaric Oxygen Compared to Air
|
Phase 2/Phase 3 | |
Completed |
NCT02432131 -
Decompression Sickness in Divers With or Without Patent Foramen Ovale
|
||
Recruiting |
NCT03192956 -
Markers of Central Nervous System Injury in Decompression Sickness
|
||
Recruiting |
NCT04791488 -
Impact of Hyperoxia and Involvement of the Immune System in Diving Accident
|
N/A | |
Completed |
NCT02736006 -
Decreases in Diffusing Lung Capacity for Carbon Monoxide (DLCO) in Occupational Divers and Their Impact on Decompression Sickness Risks
|
N/A | |
Not yet recruiting |
NCT06370897 -
Prediction & Mechanisms of Recovery Following IEDS
|
||
Not yet recruiting |
NCT06216366 -
Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers
|
Phase 2 | |
Enrolling by invitation |
NCT02483650 -
Hyperbaric Oxygen Therapy Registry
|
||
Completed |
NCT02064361 -
High Intensity Cycling Before SCUBA Diving Reduces Post-decompression Microparticle Production and Neutrophil Activation
|
N/A | |
Completed |
NCT03390335 -
Decompression Tables for Diving at Altitude
|
N/A |